Nicorettespray Fruits Rouges (Nicotine)

Nicotine, the active ingredient in Nicorettespray Fruits Rouges, is a nicotine replacement therapy presented as an oromucosal spray for oromucosal use. It helps adult smokers manage nicotine withdrawal and supports quitting tobacco use. The product is formulated to deliver a rapid, controlled dose of nicotine through the oral mucosa, mimicking the kinetic profile of cigarettes.

GNH USA supplies Nicorettespray Fruits Rouges as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable global distribution.

Nicotine spray is used in nicotine replacement therapy to aid smoking cessation by reducing withdrawal symptoms.

- Smoking cessation: assists adult smokers in quitting by providing a controlled nicotine dose to lessen cravings. - Nicotine dependence: reduces withdrawal intensity during the transition away from cigarettes. - Relapse prevention: supports individuals who have quit to maintain abstinence and avoid relapse.

Nicotine spray may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: feeling of queasiness after use. - Headache: mild to moderate headache. - Cough: transient cough after spraying.

Serious or Rare Side Effects: - Hypertension: significant increase in blood pressure. - Arrhythmia: irregular heart rhythm. - Allergic reaction: rash, swelling, or anaphylaxis.

When using Nicorettespray Fruits Rouges, consider the following precautions to ensure safe and effective use.

- Cardiovascular disease: consult a healthcare professional before use. - Pregnancy and lactation: use only if clearly needed after medical advice. - Age restriction: not recommended for persons under 18 years. - Concurrent nicotine products: avoid using other nicotine replacement therapies simultaneously. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Nicotine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis when combined with nicotine. - CYP2A6 inhibitors (e.g., methoxsalen): can increase nicotine plasma levels, raising risk of toxicity. - Beta‑blockers: nicotine may diminish their antihypertensive effect, requiring medical supervision.

Moderate Interactions (Monitor Closely): - Alcohol: concurrent use can enhance nicotine’s stimulant effects and increase cardiovascular strain. - Caffeine: may amplify nicotine‑induced jitteriness or palpitations. - Other nicotine replacement products: combined use can lead to excess nicotine exposure.